Accelero is the No. 1 for regulatory ATMP development in the German capital region. For the continuously growing number of exciting research projects, we are now offering open positions for our GLP test facility in Berlin Adlershof.
Accelero Bioanalytics GmbH (“Accelero”) announces the acquisition by the CCR Group B.V. Amsterdam, an integrated Contract Research Organization active in testing for the pharmaceutical, (agro)chemical and biotech industry.
Accelero Bioanalytics GmbH (“Accelero”) announced key figures for the fiscal year 2020 in Germany´s Federal Gazette.
Accelero Bioanalytics GmbH (“Accelero”) is awarded EUR 136,500 in project grants to support research and development of a gene therapy targeting lypodystrophy.
Accelero Bioanalytics GmbH (“Accelero”) has received the authority permit for processing and analysis of SARS-CoV-2 in biological samples.
Accelero Bioanalytics GmbH (“Accelero”) signed an agreement with the gene therapy company CombiGene AB, Lund, Sweden (“CombiGene”) to support the non-clinical development of an Adeno-associated virus (AAV) with its bioanalytical and regulatory expertise.
Accelero is pleased to announce that the company has been selected as a sustaining member of the CONELIS network life science. The CONELIS network accumulates top-class consulting services for the biotechnology and pharmaceutical industry.
Accelero is pleased to announce that the company participates as a partner organization in the Marie Curie TRAIN-HEART consortium funded by the European Commission.
Accelero Bioanalytics GmbH, a Berlin-based GLP certified bioanalytical service provider, announces today that the GLP certificate first issued in 2016 has now been renewed by the competent authority for another three years. The re-inspection has been conducted in November 2018.
The company is pleased to initiate its first formal clinical study at one of the breast cancer centres in Berlin, Germany. The study is entitled “Post-operative wound fluid collected from female breast cancer patients” and has been approved by the clinical ethics committee.
Accelero Bioanalytics GmbH
Part of the CCR Group B.V.
Volmerstrasse 9A
12489 Berlin
GERMANY
| +49 30 610 910 300 (Office) | |
| service(at)accelero-bioanalytics.com |